Navigation Links
Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries)
Date:12/8/2009

NEW YORK, Dec. 8 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries)

http://www.reportlinker.com/p0166835/European-Markets-for-Drug-Eluting-and-Bare-Metal-Stents-2009-15-Countries.html

The European market, as defined in this report, encompasses Germany, France, the United Kingdom (U.K.), Italy, Spain, Benelux (Belgium, Netherlands, and Luxemburg), Scandinavia (Finland, Denmark, Sweden, and Norway), Portugal, Austria, and Switzerland. Additional products included in this report: Bioabsorbable Stents, Bifurcated Stents and bare-metal stents.

TABLE OF CONTENTS

EUROPEAN MARKETS FOR DRUG-ELUTING AND BARE METAL STENTS 2009

(15 COUNTRIES) .......I

TABLE OF CONTENTS .................... II

LIST OF FIGURES ...V

LIST OF CHARTS VII

RESEARCH METHODOLOGY ........ 9

1.1 RESEARCH SCOPE ........................ 9

1.2 IDATA'S 9-STEP METHODOLOGY 9

Step 1: Project Initiation & Team Selection ......... 10

Step 2: Prepare Data Systems and Perform Secondary Research ... 11

Step 3: Preparation for Interviews & Questionnaire Design .......... 12

Step 4: Performing Primary Research .................. 13

Step 5: Research Analysis: Establishing Baseline Estimates .......... 15

Step 6: Market Forecast and Analysis .................. 15

Step 7: Identify Strategic Opportunities ............... 17

Step 8: Final Review and Market Release ............ 18

Step 9: Customer Feedback and Market Monitoring ....................... 19

EUROPEAN MARKET FOR INTERVENTIONAL CARDIOLOGY DEVICES....... 20

2.1 INTRODUCTION . 20

2.2 CURRENCY EXCHANGE RATES .. 21

2.3 EFFECTS OF THE ECONOMIC CRISIS ...................... 22

2.4 OVERVIEW OF THE MARKET ...... 23

2.4.1 Market Segmentation by Device Type ............. 26

2.4.2 Market Segmentation by Country ................... 33

2.4.2.1 Germany 33

2.4.2.2 France ..33

2.4.2.3 Italy ......33

2.4.2.4 Spain ....34

2.4.2.5 United Kingdom ..............34

2.4.2.6 Benelux 34

2.5 TREND ANALYSIS BY COUNTRY 38

2.6 MARKET DRIVERS ..................... 41

2.7 MARKET LIMITERS .................... 42

2.8 COMPETITIVE ANALYSIS ........... 43

2.9 MERGERS AND ACQUISITIONS ... 48

COUNTRY PROFILES ..................... 51

3.1 INTRODUCTION . 51

3.1.1 Population . 51

3.1.2 GDP per Capita ................... 51

3.1.3 PCI and DES Penetration Rates ..................... 51

3.1.4 Price Index 52

3.2 GERMANY ....... 53

3.3 FRANCE ........... 54

3.4 UNITED KINGDOM ..................... 55

3.5 ITALY .............. 56

3.6 SPAIN .............. 57

3.7 BENELUX ........ 58

3.8 SCANDINAVIA . 59

3.9 PORTUGAL ...... 60

3.10 AUSTRIA ....... 61

3.11 SWITZERLAND . 62

BARE-METAL AND DRUG-ELUTING STENTS .... 63

4.1 INTRODUCTION . 63

4.2 OVERVIEW OF THE MARKET ...... 65

4.2.1 Total Coronary Stent Market . 65

4.2.2 Bare-Metal versus Drug-Eluting Stents .......... 70

4.3 MARKET ANALYSIS AND FORECAST .................... 73

4.3.1 Bare-Metal Stent Market ..... 73

4.3.1.1 Market Analysis and Forecast ...................73

4.3.1.2 Bare-Metal Stent Market Drivers ..............78

4.3.1.3 Bare-Metal Stent Market Limiters .............78

4.3.1.4 Bare-Metal Stent Competitive Analysis .....80

4.3.2 Drug-Eluting Stent Market .. 83

4.3.2.1 Market Analysis and Forecast ...................83

4.3.2.2 Drug-Eluting Stent Market Drivers ...........87

4.3.2.3 Drug-Eluting Stent Market Limiters ..........87

4.3.2.4 Drug-Eluting Stent Competitive Analysis ..90

4.3.3 Stents in Development .......... 94

4.3.3.1 Bioabsorbable Stents ......95

4.3.3.2 Bifurcated Stents .............98

ABBREVIATIONS 101

LIST OF FIGURES

RESEARCH METHODOLOGY ...................... 9

EUROPEAN MARKET FOR INTERVENTIONAL CARDIOLOGY DEVICES.... 20

Figure 3-1: Exchange Rates for the Euro (euro), 2008 ................... 21

Figure 3-2: Market for Interventional Cardiology, Europe, 2005 - 2015 .............. 24

Figure 3-3: Market for Interventional Cardiology, Segmented by Device Type,

Europe, 2005 - 2015 (euro) . 28

Figure 3-4: Market for Interventional Cardiology, Segmented by Device Type,

Europe, 2005 - 2015 (US$) ...................... 31

Figure 3-5: Market for Interventional Cardiology, Segmented by Country,

Europe, 2005 - 2015 (euro) . 36

Figure 3-6: Market for Interventional Cardiology, Segmented by Country,

Europe, 2005 - 2015 (US$) ...................... 37

Figure 3-7: Interventional Cardiology Market Growth Rates by Country, Europe,

2005 - 2015 .................. 39

Figure 3-8: Market Drivers, European Market for Interventional Cardiology, 200841

Figure 3-9: Market Limiters, European Market for Interventional Cardiology,

2008 .. 42

Figure 3-10: Leading Competitors, Market for Interventional Cardiology, Europe,

2008 .. 44

Figure 3-11: Leading Competitors, Market for Interventional Cardiology by

Country, Europe, 2008 (Part 1) ................ 46

COUNTRY PROFILES ..... 51

Figure 5-1: Country Indicators, 2008 ............ 52

BARE-METAL AND DRUG-ELUTING STENTS .................... 63

Figure 6-1: Market for Coronary Stents by Type, Europe, 2005 - 2015 (euro) .......... 66

Figure 6-2: Market for Coronary Stents by Type, Europe, 2005 - 2015 (US$)...... 66

Figure 6-3: Market for Coronary Stents by Country, Europe, 2005 - 2015 (euro)...... 68

Figure 6-4: Market for Coronary Stents by Country, Europe, 2005 - 2015 (US$) . 69

Figure 6-5: Penetration Rate for Coronary Stents by Type, Units Sold, Europe,

2005 - 2015 .................. 70

Figure 6-6: DES Penetration by Country, Europe, 2005 - 2015 71

Figure 6-7: Market for Bare-Metal Stents by Country, Europe, 2005 - 2015 (euro)... 75

Figure 6-8: Market for Bare-Metal Stents by Country, Europe, 2005 - 2015 (US$)76

Figure 6-9: Market Drivers and Limiters, Market for Bare-Metal Stents, Europe,

2008 .. 79

Figure 6-10: Leading Competitors, Market for Bare-Metal Stents, Europe, 2008.. 81

Figure 6-11: Market for Drug-Eluting Stents by Country, Europe, 2005 - 2015 (euro)84

Figure 6-12: Market for Drug-Eluting Stents by Country, Europe, 2005 - 2015

(US$) 85

Figure 6-13: Market Drivers and Limiters, Market for Drug-Eluting Stents,

Europe, 2008 ................ 89

Figure 6-14: Leading Competitors, Market for Drug-Eluting Stents, Europe, 200892

Figure 6-15: Coronary Stent Platforms in Development, 2008 .. 94

Figure 6-16: Potential Market for Bioabsorbable Stents, Europe, 2010 - 2015 (euro) 96

Figure 6-17: Potential Market for Bioabsorbable Stents, Europe, 2010 - 2015

(US$) 96

Figure 6-18: Potential Market for Bifurcated Stents, Europe, 2010 - 2015 (euro) ..... 99

Figure 6-19: Potential Market for Bifurcated Stents, Europe, 2010 - 2015 (US$) . 99

ABBREVIATIONS ......... 101

LIST OF CHART S

RESEARCH METHODOLOGY ...................... 9

EUROPEAN MARKET FOR INTERVENTIONAL CARDIOLOGY DEVICES.... 20

Chart 3-1: Market for Interventional Cardiology, Europe, 2005 - 2015 (euro) .......... 25

Chart 3-2: Market for Interventional Cardiology, Segmented by Device Type,

Europe, 2008 ................ 30

Chart 3-3: Fastest Growing Interventional Cardiology Markets by Country,

Europe, 2005 - 2015 ..... 40

Chart 3-4: Leading Competitors, Market for Interventional Cardiology, Europe,

2008 .. 45

COUNTRY PROFILES ..... 51

Chart 5-1: German Price Index, DES Penetration, Population, GDP per Capita,

and PCI Penetration Rate, 2008 ................ 53

Chart 5-2: French Price Index, DES Penetration, Population, GDP per Capita,

and PCI Penetration Rate, 2008 ................ 54

Chart 5-3: The U.K. Price Index, DES Penetration, Population, GDP per Capita,

and PCI Penetration Rate, 2008 ................ 55

Chart 5-4: Italian Price Index, DES Penetration, Population, GDP per Capita, and

PCI Penetration Rate, 2008 ...................... 56

Chart 5-5: Spanish Price Index, DES Penetration, Population, GDP per Capita,

and PCI Penetration Rate, 2008 ................ 57

Chart 5-6: Beneluxian Price Index, DES Penetration, Population, GDP per

Capita, and PCI Penetration Rate, 2008 .... 58

Chart 5-7: Scandinavian Price Index, DES Penetration, Population, GDP per

Capita, and PCI Penetration Rate, 2008 .... 59

Chart 5-8: Portuguese Price Index, DES Penetration, Population, GDP per

Capita, and PCI Penetration Rate, 2008 .... 60

Chart 5-9: Austrian Price Index, DES Penetration, Population, GDP per Capita,

and PCI Penetration Rate, 2008 ................ 61

Chart 5-10: Swiss Price Index, DES Penetration, Population, GDP per Capita,

and PCI Penetration Rate, 2008 ................ 62

BARE-METAL AND DRUG-ELUTING STENTS .................... 63

Chart 6-1: Market for Coronary Stents by Type, Europe, 2005 - 2015 (euro)............ 67

Chart 6-2: Penetration Rate for Coronary Stents by Type, Units Sold, Europe,

2005 - 2015 .................. 72

Chart 6-3: Market for Bare-Metal Stents, Europe, 2005 - 2015 (euro) ...................... 77

Chart 6-4: Leading Competitors, Market for Bare-Metal Stents, Europe, 2008 ..... 82

Chart 6-5: Market for Drug-Eluting Stents, Europe, 2005 - 2015 (euro) ................... 86

Chart 6-6: Leading Competitors, Market for Drug-Eluting Stents, Europe, 2008 .. 93

Chart 6-7: Penetration Rate for Bioabsorbable Stents, Europe, 2010 - 2015......... 97

Chart 6-8: Penetration Rate for Bifurcated Stents, Europe, 2010 - 2015 ............ 100

ABBREVIATIONS ......... 101

To order this report:

Cardiovascular Devices Industry: European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries)

More Market Research Report


Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker


'/>"/>
SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis
2. Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective
3. Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis
4. Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review
5. Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review
6. Reportlinker Adds Radiation Therapy Equipment - A Global Market Review
7. Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities
8. Reportlinker Adds Training Manikins - Global Trends
9. Reportlinker Adds Immunoassay Instruments - Global Market Trends
10. Reportlinker Adds Hospital Information Systems - A Global Update of Market Trends & Opportunities
11. Reportlinker Adds Arthroscopes - A World Market Review
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... -- Research and Markets has announced the addition ... to their offering. The ... commercial environment for MedImmune to enter. The US ageing population ... to drive considerable growth for effective anti-influenza medications. The introduction ... considerably, but development is still in its infancy. ...
(Date:6/23/2016)... 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in ... America . ... ... ... ...
(Date:6/23/2016)... 2016 Research and Markets has ... Global Analysis (United States, China, Japan, Brazil, United Kingdom, ... their offering. Surgical ... business planners, provides surgical procedure volume data in a ... an in-depth analysis of growth drivers and inhibitors, including ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, ... Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. ... skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
(Date:6/24/2016)... San Diego, CA (PRWEB) , ... June 24, 2016 , ... ... up with the American Cancer Society and the Road To Recovery® program to drive ... care to seniors and other adults to ensure the highest quality of life and ...
(Date:6/24/2016)... Vegas, Nevada (PRWEB) , ... June 24, 2016 ... ... Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing ... Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of ...
Breaking Medicine News(10 mins):